Stomach Cancer Could Have Been Easily Treatable If Sanofi Warned of Zantac Cancer Sooner

Plaintiffs are infuriated that Sanofi allegedly covered-up what they knew about Zantac cancer

Wednesday, September 30, 2020 - Cancer is probably the most feared of all diseases because so many of its victims eventually die from the disease. Zantac, The popular and best-selling anti-heartburn and acid reflux medicine, is alleged to contain a substance that has caused thousands and maybe millions of people around the world to develop a wide variety of cancer like stomach, bladder, esophagus, intestinal, prostate, colon, and breast cancer. The average life expectance of cancer patients taken as a whole is about three to five years. How long one lives after their cancer diagnosis depends on how difficult the disease is to treat, and that depends on how early one discovers and treats the disease. Cancer has a latency period of around 10 years in general before the patients become aware they have a problem. Stage one cancer is localized and easier to surgically remove in most cases, and then treat the affected area with radiation. In stage four the disease has spread to a vital organ through the bloodstream and only dangerous chemotherapy is an option. Discovering and treating cancer early on is one good reason plaintiffs are infuriated that Sanofi, the maker of Zantac, may have failed to warn consumers of what they knew or had an obligation to know, for over a decade about Zantac having the likelihood of containing a cancer-causing substance. All the while, Sanofi pocketed billions of dollars of profits while keeping their mouths shut.

Sanofi's alleged fraud and negligence may have caused the cancer deaths of thousands of Americans and the US Government is investigating the company for wrongdoing. According to S&P Market Intelligence, "Sanofi and GlaxoSmithKline PLC are facing an investigation by the U.S. Department of Justice related to heartburn drug Zantac, which was recalled from the market in April on reports of cancer-causing impurities in the medicine. The U.S. DOJ and the U.S. Attorney's Office for the Eastern District of Pennsylvania gave notice of an investigation in June. The inquiry will look into allegations that pharmaceutical manufacturers violated the False Claims Act by failing to disclose information about the potential presence of N-Nitrosodimethylamine, or NDMA, in the drug, Paris-based Sanofi noted in its half-year financial report." If your or a loved one has developed cancer you should seek guidance from a Zantac Cancer Lawyer to see if you qualify to file a claim to be reimbursed for medical expenses, lost wages, pain, and suffering, and any other related damages you may have suffered including lump-sum punitive damages.

NoStomachForCancer.org educates people on the dangers of stomach cancer and what to look for that would indicate you may have it. NSFC describes the difficulty of diagnosing stomach cancer early. "Early-stage stomach cancer rarely causes symptoms, making early detection very difficult. Stomach cancer may or may not present with vague gastrointestinal symptoms, including indigestion, abdominal pain or discomfort, nausea, and vomiting, bloating, or the feeling of fullness when eating a meal (also called early satiety). " It is interesting to note that these symptoms mirror the type of discomfort people feel when they started to take Zantac.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.